SCHEMBL23168751

SCHEMBL23168751

Cc1ccc(Cn2cc(Oc3c(Cl)cc(N)cc3Cl)ccc2=O)cc1C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NPBWR1 P48145 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ P2RX7 Q99572 6/20 0.37
▸ SDHB P21912 2/20 0.36
▸ CYP1A2 P05177 2/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ LMNA P02545 2/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23168748 0.87 P2RX7 (0.37) NPBWR1MAPTP2RX7SDHBCYP1A2
SCHEMBL23168775 0.84 MAPT (0.43) NPBWR1MAPTCYP1A2CYP3A4CYP2D6
SCHEMBL23168745 0.83 KLKB1 (0.40) NPBWR1ALDH1A1
SCHEMBL23168940 0.82 MAPT (0.40) MAPTP2RX7LMNAKMT2ATP53
SCHEMBL23168931 0.82 NPBWR1 (0.46) NPBWR1MAPTSDHBLMNATP53
SCHEMBL24819269 0.82 NPBWR1 (0.50) NPBWR1MAPTP2RX7LMNATP53
SCHEMBL29822136 0.82 NPBWR1 (0.50) NPBWR1MAPTP2RX7LMNATP53
SCHEMBL23168951 0.81 MAPT (0.40) MAPTP2RX7CYP1A2CYP3A4CYP2D6
SCHEMBL31356395 0.81 MAPT (0.40) MAPTP2RX7CYP1A2CYP3A4CYP2D6
SCHEMBL24820993 0.79 MKNK1 (0.42) NPBWR1MAPTCYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021057791-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF 广东东阳光药业有限公司 2021-04-01 — — WO disclosed
Send feedback